RTRX News Alert Retrophin Inc (RTRX) 12.92 12/25/2014 13:50:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Retrophin Inc (RTRX) 12.92 $RTRX

Commit To Buy Retrophin At $10, Earn 28.9% Annualized Using Options
StockOptionsChannel.com - Wed Dec 24, 11:18AM CST
Investors considering a purchase of Retrophin, Inc. shares, but cautious about paying the going market price of $12.82/share, might benefit from considering selling puts among the alternative strategies at their disposal.
RTRX: 12.92 (+0.19)

Attention Retrophin, Inc. (RTRX) Shareholders: Retrophin Mislead Investors According to a Newly Filed Class Action
GlobeNewswire - Mon Dec 22, 7:18PM CST
Shareholder rights law firm Robbins Arroyo LLP announces that an investor of Retrophin, Inc. (Nasdaq:RTRX) has filed a federal securities fraud class action complaint in the U.S. District Court for the Southern District of New York. The complaint alleges that the company and certain of its officers and directors violated the Securities Exchange Act of 1934 between November 13, 2013 and September 30, 2014. Retrophin is a biopharmaceutical company that develops, acquires, and commercializes therapies for the treatment of serious, catastrophic, and rare diseases.
RTRX: 12.92 (+0.19)

The Winners for Best and Worst Biotech CEOs of 2014 Are...
at The Street - Thu Dec 18, 9:01AM CST
Congrats to David Schenkhein of Agios and Nick Leschly of Bluebird Bio for snagging 'Best' honors, while the ignominious (dis)honor of 'Worst' goes to Martin Shkreli, formerly of Retrophin.
BLUE: 88.76 (+3.23), RTRX: 12.92 (+0.19), AGIO: 109.67 (+2.45)

UPCOMING DEADLINE: The Law Offices of Vincent Wong Notify Investors of Class Action Involving Retrophin, Inc. and a Lead Plaintiff Deadline of December 19, 2014 -- RTRX
GlobeNewswire - Tue Dec 16, 3:54PM CST
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Retrophin, Inc. ("Retrophin" or the "Company" (Nasdaq:RTRX) securities between March 27, 2014 and September 30, 2014.
RTRX: 12.92 (+0.19)

Retrophin Announces Addition to the NASDAQ Biotechnology Index
Business Wire - Tue Dec 16, 7:00AM CST
Retrophin, Inc. (NASDAQ:RTRX) today announced that it has been selected for addition to the NASDAQ Biotechnology Index (NASDAQ:NBI). The addition will become effective prior to market open on Monday, December 22, 2014.
RTRX: 12.92 (+0.19)

Nasdaq makes annual changes to Biotechnology Index
Seeking Alpha - at Seeking Alpha - Mon Dec 15, 11:36AM CST

TTPH: 38.86 (+0.53), ZSPH: 43.93 (+1.77), AMRN: 0.99 (unch), OPHT: 44.93 (+1.06), AERI: 29.49 (+1.23), ASPX: 49.93 (-0.10), CNCE: 11.76 (+0.11), ICEL: 5.74 (-0.18), GWPH: 68.08 (+1.82), AUXL: 34.40 (+0.18), RTRX: 12.92 (+0.19), RCPT: 122.05 (+4.05), AAVL: 47.30 (-1.20), AKBA: 11.23 (-0.31), EXPR: 14.96 (+0.32), RARE: 45.17 (-0.56), RLYP: 30.35 (-0.22), PETX: 17.05 (+0.42), ENTA: 49.04 (+0.06), RDUS: 37.17 (+0.11), CARA: 9.78 (+0.02), FLML: 17.01 (-0.98), ALIM: 5.43 (-0.06), ANIP: 55.24 (+1.79), ICPT: 151.49 (+5.85), RVNC: 16.65 (+0.42), POZN: 7.86 (+0.07), FPRX: 26.12 (+0.07), ZFGN: 30.99 (+0.67), CRIS: 1.29 (+0.04), QLTI: 3.72 (+0.08), PCYC: 121.84 (+1.15), PTX: 9.05 (+0.28), CLDN: 18.54 (+0.85), RIGL: 2.22 (+0.02), HPTX: 21.91 (-0.08), AMPH: 11.74 (-0.09), INO: 9.11 (-0.09), VSAR: 22.25 (-0.11), FMI: 23.99 (-0.10), TBPH: 14.84 (+0.20), XLRN: 38.80 (+0.80), MGNX: 33.00 (+0.34), INSM: 15.29 (+0.15), ONTX: 3.82 (+0.06), ALDR: 25.67 (+0.43), SAGE: 38.13 (-0.75), KITE: 51.96 (+0.45), CGEN: 8.58 (-0.17), FOLD: 7.94 (+0.06), KPTI: 37.78 (+1.28)

Nominees for Absolute Worst Bio-Technology CEOs of 2014 Are ...
at The Street - Mon Dec 15, 10:49AM CST
The CEOs of Aegerion, Dendron, CytRx, Galena, Repros, Northwest Bio and Retrophin deserve jeers for their performances this year, but who's the worst of the bunch?
NWBO: 5.58 (+0.04), DNDN: 0.13 (-0.02), RTRX: 12.92 (+0.19), CYTR: 2.58 (+0.03), RPRX: 8.88 (+0.24), GALE: 1.49 (-0.02), AEGR: 21.59 (-0.27)

Annual Changes to the NASDAQ Biotechnology Index
GlobeNewswire - Mon Dec 15, 6:10AM CST
The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) today announced the results of the annual re-ranking of the NASDAQ Biotechnology Index (Nasdaq:NBI), which will become effective prior to market open on Monday, December 22, 2014.
TTPH: 38.86 (+0.53), ZSPH: 43.93 (+1.77), AMRN: 0.99 (unch), OPHT: 44.93 (+1.06), AERI: 29.49 (+1.23), ASPX: 49.93 (-0.10), CNCE: 11.76 (+0.11), ICEL: 5.74 (-0.18), GWPH: 68.08 (+1.82), AUXL: 34.40 (+0.18), RTRX: 12.92 (+0.19), RCPT: 122.05 (+4.05), AAVL: 47.30 (-1.20), AKBA: 11.23 (-0.31), EXPR: 14.96 (+0.32), RARE: 45.17 (-0.56), ZGNX: 1.20 (+0.04), RLYP: 30.35 (-0.22), PETX: 17.05 (+0.42), ENTA: 49.04 (+0.06), RDUS: 37.17 (+0.11), CARA: 9.78 (+0.02), FLML: 17.01 (-0.98), ALIM: 5.43 (-0.06), ANIP: 55.24 (+1.79), ICPT: 151.49 (+5.85), RVNC: 16.65 (+0.42), POZN: 7.86 (+0.07), NDAQ: 48.74 (-0.40), FPRX: 26.12 (+0.07), CRIS: 1.29 (+0.04), ZFGN: 30.99 (+0.67), QLTI: 3.72 (+0.08), PCYC: 121.84 (+1.15), PTX: 9.05 (+0.28), CLDN: 18.54 (+0.85), RIGL: 2.22 (+0.02), HPTX: 21.91 (-0.08), AMPH: 11.74 (-0.09), INO: 9.11 (-0.09), VSAR: 22.25 (-0.11), FMI: 23.99 (-0.10), TBPH: 14.84 (+0.20), XLRN: 38.80 (+0.80), MGNX: 33.00 (+0.34), INSM: 15.29 (+0.15), ONTX: 3.82 (+0.06), ALDR: 25.67 (+0.43), SAGE: 38.13 (-0.75), KITE: 51.96 (+0.45), CGEN: 8.58 (-0.17), FOLD: 7.94 (+0.06), KPTI: 37.78 (+1.28)

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Retrophin, Inc. of Class Action Lawsuit and Upcoming Deadline -- RTRX
GlobeNewswire - Fri Dec 12, 6:43PM CST
Pomerantz LLP has filed a class action lawsuit against Retrophin, Inc. ("Retrophin" or the "Company" (Nasdaq:RTRX) and certain of its officers. The class action, filed in United States District Court, Southern District of New York, and docketed under 14-cv-8376, is on behalf of a class consisting of all persons or entities who purchased Retrophin securities between March 27, 2014 and September 30, 2014, inclusive (the "Class Period" . This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act" .
RTRX: 12.92 (+0.19)

INVESTOR ALERT: Class Action Lawsuit Against Retrophin, Inc. Announced by Law Offices of Howard G. Smith
Business Wire - Fri Dec 12, 3:59PM CST
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed in the United States District Court for the Southern District of California on behalf of purchasers of the securities of Retrophin, Inc. ("Retrophin" or the "Company" (NASDAQ:RTRX) between March 27, 2014 and September 30, 2014, inclusive (the "Class Period" .
RTRX: 12.92 (+0.19)

Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action against Retrophin, Inc. and Lead Plaintiff Deadline of December 19, 2014
PR Newswire - Fri Dec 12, 9:00AM CST
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed in the United States District Court for the Southern District of New York on behalf of those who purchased shares of Retrophin, Inc. ("Retrophin" or the "Company" (NasdaqGM: RTRX), during the period between March 27, 2014 and September 30, 2014, inclusive (the "Class Period" .
RTRX: 12.92 (+0.19)

SHAREHOLDER ALERT: Investigation on Behalf of Retrophin, Inc. Investors Announced by Law Offices of Howard G. Smith
Business Wire - Thu Dec 11, 12:54PM CST
Law Offices of Howard G. Smith announces that it is investigating potential claims on behalf of investors of Retrophin, Inc. ("Retrophin" or the "Company" (NASDAQ:RTRX) concerning possible violations of federal securities laws. The investigation is focused on the Company's operations. Retrophin is a biopharmaceutical company, focused on the development, acquisition and commercialization of therapies for the treatment of serious, catastrophic or rare diseases.
RTRX: 12.92 (+0.19)

INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Retrophin, Inc.
Business Wire - Wed Dec 10, 5:13PM CST
Glancy Binkow & Goldberg LLP reminds investors of Retrophin, Inc. ("Retrophin" or the "Company" (NASDAQ:RTRX) that purchasers of Retrophin securities between March 27, 2014 and September 30, 2014, inclusive (the "Class Period" , have until December 19, 2014, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit filed in the United States District Court for the Southern District of California.
RTRX: 12.92 (+0.19)

UPCOMING DEADLINE: LEVI & KORSINSKY, LLP Reminds Investors of Class Action Against Retrophin, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 19, 2014 -- RTRX
GlobeNewswire - Mon Dec 08, 12:12PM CST
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who purchased Retrophin, Inc. ("Retrophin" or the "Company" (Nasdaq:RTRX) securities between March 27, 2014 and September 30, 2014.
RTRX: 12.92 (+0.19)

Brinson Patrick's Christopher S. James: All Catalysts Are Not Created Equal
Life Sciences Report - Seeking Alpha - Fri Dec 05, 7:55AM CST
Why do some good-news milestones cause stocks to languish, or even fall? Neurosurgeon Christopher James, managing director and senior biotechnology analyst at Brinson Patrick Securities, performs due diligence on stocks, in part, by connecting his...
BCRX: 11.83 (+0.76), STEM: 0.90 (+0.03), RTRX: 12.92 (+0.19), RGLS: 14.78 (+0.24), SNY: 46.35 (+0.50), MNKD: 5.68 (+0.18)

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Retrophin, Inc. To Contact Brower Piven Before The December 19, 2014 Lead Plaintiff Deadline In Class Action Lawsuit
Business Wire - Mon Dec 01, 4:00PM CST
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of California on behalf of purchasers of Retrophin, Inc. ("Retrophin" or the "Company" (NASDAQ: RTRX) securities during the period between March 27, 2014 and September 30, 2014, inclusive (the "Class Period" . Investors who wish to become proactively involved in the litigation have until December 19, 2014 to seek appointment as lead plaintiff.
RTRX: 12.92 (+0.19)

Ousted Retrophin CEO Sold Stock While Urging Investors to Buy
at The Street - Tue Nov 25, 11:41AM CST
Martin Shkreli, the ousted CEO of Retrophin, received $3 million from selling company stock but delayed disclosure for two months, a new SEC filing shows.
RTRX: 12.92 (+0.19)

InsiderInsights.com Daily Round Up 11/24/14: CLD, OPK, HTZ, DEI
InsiderInsights - at Seeking Alpha - Tue Nov 25, 10:03AM CST

SNBC: 19.69 (-0.29), JASN: 9.84 (-0.06), HTZ: 24.38 (-0.09), APAM: 49.54 (-0.27), MMI: 33.68 (+0.05), STX: 68.82 (+0.17), DEI: 28.75 (-0.13), MRD: 18.64 (-0.53), PAH: 23.00 (+0.01), SGM: 12.35 (+0.05), CLD: 9.45 (-0.26), W: 20.44 (-0.35), SHOO: 31.55 (-0.09), INT: 47.79 (-0.05), OPK: 9.63 (+0.21), RTRX: 12.92 (+0.19), SFXE: 4.42 (+0.04), NNBR: 19.77 (+0.26), APD: 148.58 (unch)

UPCOMING DEADLINE: LEVI & KORSINSKY, LLP Reminds Investors of Class Action against Retrophin, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 19, 2014
Business Wire - Mon Nov 24, 3:52PM CST
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who purchased Retrophin, Inc. ("Retrophin" or the "Company" (NasdaqGM:RTRX) securities between March 27, 2014 and September 30, 2014.
RTRX: 12.92 (+0.19)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

PayPal's New Leadership Map Puts Execution on Trial

Updated Category News Views 106

Four senior appointments and a risk-chief exit can turn a tidy strategy slide into a very real operating test. PayPal has spent months defining three-year plans, simplifying its operating model and assigning clearer accountability; on November 20, it put names beside the jobs. For NASDAQ:PYPL investors, that is more consequential than another broad promise about...

Continue Reading
Rosalind Franklin University’s $23.8M Scholarship Win

Updated Category News Views 58

Twenty-three million dollars can disappear fast in graduate health education, which is exactly why Rosalind Franklin University’s campaign result deserves more than a polite round of applause. The university’s five-year Empowering Scholars effort closed in June 2026 with $23,836,272 raised, clearing its $20 million target by roughly 19%. In a world where institutions...

Continue Reading
Millrose Lawsuit Puts Disclosure Discipline in Focus

Updated Category News Views 64

A supposedly clean homesite-option story has wandered into the legal weeds, and that is exactly where investors need to slow down. A shareholder class action against Millrose Properties alleges the company painted one business model for the market while pursuing a materially different one behind the curtain. That allegation has not been proven in court, and anybody...

Continue Reading
Clear Aligner Results Depend on Discipline, Not Hype

Updated Category News Views 103

A Clear Tray Is Not a Magic Wand Transparent orthodontic trays sell a wonderfully tidy idea: straighten teeth without the metal-and-wire routine, take them out to eat, and carry on. Fair enough. But the useful message from Dr. Theresa Trapp is the part nobody should glide past: clear aligners are a treatment plan, not a cosmetic shortcut bought with good intentions....

Continue Reading
Korla Kiln Gains Show How Cement Efficiency Is Won

Updated Category News Views 93

A cement kiln does not care about corporate slogans; it cares whether the flame holds, the bearings stay alive, and the feed keeps moving. That is why the work at Xinjiang Tianshan Cement's Tashidian branch in Korla deserves a closer look. This is not a glossy tale about a futuristic factory appearing overnight. It is an account of an old, unforgiving industrial process...

Continue Reading
KONST Pitches Asia GPU Uptime as AI Demand Gets Real

Updated Category News Views 115

GPU racks are easy to admire when the lights are on; keeping them useful at 3 a.m. is where the bruises show. KONST arrived at SC26 in Chicago with a sensible pitch for an AI-infrastructure market that is getting less impressed by shiny hardware lists and more obsessed with whether the thing actually works. Its theme, “24/7 GPUs Delivered in Asia,” puts the emphasis...

Continue Reading
Epilepsy Campaign Puts Patient Voices Before Investors

Updated Category News Views 28

An epilepsy diagnosis can turn ordinary family routines into a maze overnight, which is why awareness work deserves more than the usual polite nod and a colored ribbon. Mediaplanet's national Epilepsy Awareness campaign, launched November 20, 2026, brings the subject into a USA TODAY print insert and related digital coverage during Epilepsy Awareness Month. That reach...

Continue Reading
ASU's International Enrollment Lead Carries Real Weight

Updated Category News Views 108

Twenty thousand nine hundred twenty-six international students is not a campus footnote; it is a serious operating force moving through Arizona State University and the state around it. ASU has held the No. 1 spot among U.S. public universities hosting international students for six straight years, and the 2026 Open Doors report puts it No. 2 across public and private...

Continue Reading
Mars Sets $2 Billion Debt Tender With Kellanova Notes

Updated Category News Views 93

A two-billion-dollar vacuum cleaner just switched on inside Mars’s debt stack, and the timing is anything but casual. On November 20, Mars fixed the pricing for cash tender offers spanning selected Mars and Kellanova senior notes, with holders facing a 5:00 p.m. New York deadline that same day. This is the kind of filing that looks like bond-market plumbing until you...

Continue Reading
Branch's Fast 500 Rank Signals Payroll Platform Reach

Updated Category News Views 58

Six straight appearances on Deloitte's Fast 500 is not random confetti; it says Branch has kept finding customers while plenty of fintech outfits were busy shrinking their ambitions. The Tampa-based workforce-payments company landed at No. 146 in the 2026 ranking, which measures fiscal-year revenue growth from 2022 through 2025. That is a respectable showing in a list...

Continue Reading

Top 5 Most Recently Viewed Articles

AI/R Targets 2025 IPO Amidst Rapid AI Advancements

Updated Category News Views 488

AI/R Sets 2025 IPO Goals as AI Innovations Surge AI/R, a leading provider of artificial intelligence platforms and services, has exciting plans for a public offering in 2025. As a global player in the AI industry, renowned companies like Toyota, BP, and Nestlé benefit from AI/R's innovative solutions. The company anticipates impressive revenues exceeding $350 million for...

Continue Reading
Sable Implements New Equity Plan to Enhance Shareholder Value

Updated Category News Views 228

Sable Resources Ltd. Unveils Innovative Equity Incentive Plan VANCOUVER, British Columbia — Sable Resources Ltd. (“Sable” or the “Company”) (TSXV: SAE | OTCQB: SBLRF) has announced an exciting new chapter for the company with the recent approval of its Equity Incentive Plan at the annual shareholder meeting. The approval reflects strong support from...

Continue Reading
Unlock Savings This Black Friday with AKKO's Amazing Deals

Updated Category News Views 163

Get Ready for AKKO's Black Friday Extravaganza As the holiday season draws near, AKKO is set to surprise European users with spectacular Black Friday deals. During this promotional event, you can enjoy discounts of up to 50% on premium mechanical keyboards, keycaps, and various accessories. Whether you are a competitive gamer seeking high performance or an everyday user...

Continue Reading
Ping An Health Sets Benchmark with WONCA Certifications in Care

Updated Category News Views 156

Ping An Health Achieves Notable WONCA Certifications Recently, Ping An Healthcare Technology Co., Ltd. successfully obtained the prestigious Digital Health Certificate (DHC) and the Development & Enhancement Program (DEP) Certificate from the World Organization of Family Doctors (WONCA). This makes Ping An Health the first healthcare and eldercare service company in the...

Continue Reading
Gallatin AI's Navigator Solution Gains DoD Recognition

Updated Category News Views 277

Gallatin AI's Navigator Solution Gains 'Awardable' Status Gallatin AI, an innovative startup committed to evolving defense logistics, has announced significant news regarding its flagship product, Gallatin Navigator. This advanced logistics operating system has officially achieved 'Awardable' status under the Department of Defense's Tradewinds Solutions Marketplace. This...

Continue Reading